KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nu Skin Enterprises (NUS) Cash & Equivalents: 2009-2024

Historic Cash & Equivalents for Nu Skin Enterprises (NUS) over the last 16 years, with Dec 2024 value amounting to $186.9 million.

  • Nu Skin Enterprises' Cash & Equivalents rose 10.55% to $251.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $251.8 million, marking a year-over-year increase of 10.55%. This contributed to the annual value of $186.9 million for FY2024, which is 27.02% down from last year.
  • According to the latest figures from FY2024, Nu Skin Enterprises' Cash & Equivalents is $186.9 million, which was down 27.02% from $256.1 million recorded in FY2023.
  • In the past 5 years, Nu Skin Enterprises' Cash & Equivalents registered a high of $402.7 million during FY2020, and its lowest value of $186.9 million during FY2024.
  • Moreover, its 3-year median value for Cash & Equivalents was $256.1 million (2023), whereas its average is $235.9 million.
  • In the last 5 years, Nu Skin Enterprises' Cash & Equivalents increased by 19.98% in 2020 and then dropped by 27.02% in 2024.
  • Over the past 5 years, Nu Skin Enterprises' Cash & Equivalents (Yearly) stood at $402.7 million in 2020, then fell by 15.67% to $339.6 million in 2021, then declined by 22.05% to $264.7 million in 2022, then dropped by 3.27% to $256.1 million in 2023, then dropped by 27.02% to $186.9 million in 2024.